Literature DB >> 6212006

Clinical and laboratory manifestations of toxic shock syndrome.

R W Tofte, D N Williams.   

Abstract

We studied 28 women and two men, with a median age of 20 years, who first had toxic shock syndrome between 1 February 1980 and 15 July 1981. Two of these patients died. All patients had intense myalgia, high fever (greater than or equal to 38.9 degrees C), hypotension or syncope, skin rash and desquamation, and abnormalities in at least three organ systems. Over half had sterile pyuria; immature granulocytic leukocytosis; coagulation abnormalities; hypocalcemia; low serum albumin and total protein concentrations; and elevations of blood urea nitrogen, alanine transaminase, bilirubin, and creatine kinase. Staphylococcus aureus was isolated from cultures from sites of soft-tissue infection in both male patients and from 13 of 19 vaginal and eight of 12 cervical cultures. All isolates produced both pyrogenic exotoxin C and enterotoxin F. All patients with a febrile, exanthematous, multisystem illness, particularly one associated with menstruation or a staphylococcal infection, should be promptly evaluated and empirically treated for toxic shock syndrome.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6212006     DOI: 10.7326/0003-4819-96-6-843

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  13 in total

1.  Internal medicine-important advances in clinical medicine: toxic shock syndrome.

Authors:  C J Fisher
Journal:  West J Med       Date:  1983-05

2.  Persistent bactericidal defect in neutrophils from a young woman who recovered from toxic shock syndrome.

Authors:  E M Berger; C J Beehler; J E Repine
Journal:  Inflammation       Date:  1986-12       Impact factor: 4.092

Review 3.  Toxic shock syndrome.

Authors:  J K Todd
Journal:  Clin Microbiol Rev       Date:  1988-10       Impact factor: 26.132

4.  Systemic septic embolisation secondary to an atrial myxoma in a young woman.

Authors:  Alice M Veitch; Nathan E Manghat; Nirmal K Kakani; C Terence Lewis; Nicholas J Ring
Journal:  Emerg Radiol       Date:  2006-01-26

5.  An unusual systemic staphylococcal illness with features of the mucocutaneous lymph node syndrome.

Authors:  K S Servilla; J A Green; H J Williams; J J Zone
Journal:  West J Med       Date:  1985-02

6.  Enhanced cytokine-induced mechanical hyperalgesia in skeletal muscle produced by a novel mechanism in rats exposed to unpredictable sound stress.

Authors:  Olayinka A Dina; Jon D Levine; Paul G Green
Journal:  Eur J Pain       Date:  2011-03-17       Impact factor: 3.931

7.  Association between high antistaphylolysin and teichoic acid antibody titres with rheumatic syndromes.

Authors:  J M Valtonen; M T Syrjälä; V V Valtonen
Journal:  Clin Rheumatol       Date:  1997-11       Impact factor: 2.980

Review 8.  Toxic shock syndrome: a review of the literature.

Authors:  D Thomas; P S Withington
Journal:  Ann R Coll Surg Engl       Date:  1985-05       Impact factor: 1.891

9.  Staphylococcus aureus triggered reactive arthritis.

Authors:  A R Siam; M Hammoudeh
Journal:  Ann Rheum Dis       Date:  1995-02       Impact factor: 19.103

10.  Affinity purification of staphylococcal toxic shock syndrome toxin 1 and its pathologic effects in rabbits.

Authors:  M W Reeves; R J Arko; F W Chandler; N B Bridges
Journal:  Infect Immun       Date:  1986-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.